Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Aquinox Pharmaceuticals (AQXP) Competitors

Aquinox Pharmaceuticals logo

AQXP vs. DYN, AUPH, SNDX, BGM, WVE, OPK, ETNB, COLL, MLYS, and HROW

Should you be buying Aquinox Pharmaceuticals stock or one of its competitors? The main competitors of Aquinox Pharmaceuticals include Dyne Therapeutics (DYN), Aurinia Pharmaceuticals (AUPH), Syndax Pharmaceuticals (SNDX), Qilian International Holding Group (BGM), Wave Life Sciences (WVE), OPKO Health (OPK), 89bio (ETNB), Collegium Pharmaceutical (COLL), Mineralys Therapeutics (MLYS), and Harrow (HROW). These companies are all part of the "medical" sector.

Aquinox Pharmaceuticals vs.

Aquinox Pharmaceuticals (NASDAQ:AQXP) and Dyne Therapeutics (NASDAQ:DYN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment, community ranking and earnings.

Dyne Therapeutics has a consensus target price of $47.46, indicating a potential upside of 320.76%. Given Dyne Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Dyne Therapeutics is more favorable than Aquinox Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aquinox Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Dyne Therapeutics
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
3.07

Aquinox Pharmaceuticals has higher revenue and earnings than Dyne Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aquinox Pharmaceuticals$25M13.65-$31.58MN/AN/A
Dyne TherapeuticsN/AN/A-$235.94M-$3.35-3.37

In the previous week, Dyne Therapeutics had 12 more articles in the media than Aquinox Pharmaceuticals. MarketBeat recorded 12 mentions for Dyne Therapeutics and 0 mentions for Aquinox Pharmaceuticals. Dyne Therapeutics' average media sentiment score of 0.56 beat Aquinox Pharmaceuticals' score of 0.00 indicating that Dyne Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Aquinox Pharmaceuticals Neutral
Dyne Therapeutics Positive

Aquinox Pharmaceuticals has a beta of -7.37, meaning that its stock price is 837% less volatile than the S&P 500. Comparatively, Dyne Therapeutics has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500.

71.7% of Aquinox Pharmaceuticals shares are held by institutional investors. Comparatively, 96.7% of Dyne Therapeutics shares are held by institutional investors. 4.0% of Aquinox Pharmaceuticals shares are held by company insiders. Comparatively, 20.8% of Dyne Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Aquinox Pharmaceuticals received 255 more outperform votes than Dyne Therapeutics when rated by MarketBeat users. However, 77.19% of users gave Dyne Therapeutics an outperform vote while only 71.88% of users gave Aquinox Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
Aquinox PharmaceuticalsOutperform Votes
299
71.88%
Underperform Votes
117
28.13%
Dyne TherapeuticsOutperform Votes
44
77.19%
Underperform Votes
13
22.81%

Aquinox Pharmaceuticals' return on equity of -30.13% beat Dyne Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Aquinox PharmaceuticalsN/A -30.13% -28.08%
Dyne Therapeutics N/A -57.46%-51.62%

Summary

Dyne Therapeutics beats Aquinox Pharmaceuticals on 10 of the 15 factors compared between the two stocks.

Get Aquinox Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AQXP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AQXP vs. The Competition

MetricAquinox PharmaceuticalsPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$341.33M$6.74B$5.47B$7.80B
Dividend YieldN/A3.11%5.42%4.24%
P/E RatioN/A7.2722.3118.46
Price / Sales13.65241.32394.17104.18
Price / CashN/A65.8538.1834.62
Price / Book4.696.356.724.21
Net Income-$31.58M$143.17M$3.22B$248.18M

Aquinox Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AQXP
Aquinox Pharmaceuticals
N/A$14.50
-5.9%
N/A-48.6%$341.33M$25M0.008
DYN
Dyne Therapeutics
3.3003 of 5 stars
$9.33
+14.2%
$47.46
+408.7%
-54.4%$1.06BN/A-2.62100Upcoming Earnings
Short Interest ↑
High Trading Volume
AUPH
Aurinia Pharmaceuticals
2.8066 of 5 stars
$7.66
-1.2%
$11.50
+50.1%
+62.9%$1.05B$235.13M-51.06300Upcoming Earnings
Positive News
SNDX
Syndax Pharmaceuticals
3.6477 of 5 stars
$11.93
+3.4%
$36.20
+203.4%
-36.3%$1.03B$23.68M-3.29110Upcoming Earnings
News Coverage
Positive News
BGM
Qilian International Holding Group
N/A$10.52
-4.4%
N/AN/A$1.02B$25.10M0.00298News Coverage
WVE
Wave Life Sciences
4.3007 of 5 stars
$6.12
+3.4%
$22.18
+262.4%
+46.6%$939.33M$108.30M-5.51240
OPK
OPKO Health
4.4669 of 5 stars
$1.37
-3.5%
$2.75
+100.7%
+11.9%$920.02M$713.14M-7.214,200Upcoming Earnings
Short Interest ↓
Positive News
ETNB
89bio
3.0084 of 5 stars
$6.27
+3.5%
$27.56
+339.5%
-10.4%$915.32MN/A-2.1540Gap Down
COLL
Collegium Pharmaceutical
4.0228 of 5 stars
$26.91
-0.4%
$43.60
+62.0%
-26.2%$864.67M$631.45M11.60210Positive News
MLYS
Mineralys Therapeutics
2.4162 of 5 stars
$13.24
-0.8%
$33.00
+149.2%
+14.2%$858.96MN/A-3.6428Short Interest ↑
HROW
Harrow
2.5149 of 5 stars
$23.24
-3.1%
$60.50
+160.3%
+134.1%$828.60M$199.61M-24.72182Positive News

Related Companies and Tools


This page (NASDAQ:AQXP) was last updated on 4/29/2025 by MarketBeat.com Staff
From Our Partners